Medical News

RSS

Celleration initiates enrollment in MIST Therapy study for VLU

Celleration, Inc., a privately-held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announced the first patient enrollment in IN-BALANCE VLU (Inflammation, Bacteria, & Angiogenesis effects in Launching Venous Leg Ulcer healing: A Clinical Evaluation).

15 May 2012

USPTO issues new patent to Excelsior Medical's SwabKIT

Excelsior Medical Corporation announced that the United States Patent and Trademark Office (USPTO) has issued new US Patent No. 8,167,847 to the company. The patent relates to an antiseptic cap and antiseptic cap equipped plunger and syringe barrel assembly.

15 May 2012

IMRIS first quarter revenues decrease to $3.5 million

IMRIS Inc. today reported its results for the first quarter of 2012. All figures are reported in US dollars.

15 May 2012

Smoked cannabis may be an effective treatment for spasticity

A clinical study of 30 adult patients with multiple sclerosis (MS) at the University of California, San Diego School of Medicine has shown that smoked cannabis may be an effective treatment for spasticity - a common and disabling symptom of this neurological disease.

15 May 2012

Research addresses age-old question of why women love bad boys

Nice guys do finish last at least when it comes to procreation according to a study from The University of Texas at San Antonio that answers the question of why women choose bad boys.

15 May 2012

Latest research on caring for ischemic stroke patients

Following a stroke, factors as varied as blood sugar, body temperature and position in bed can affect patient outcomes, Loyola University Medical Center researchers report.

15 May 2012

AxoGen first quarter revenues increase 47% to $1.65 million

AxoGen, Inc., a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced revenues for the first quarter ended March 31, 2012 of $1.65 million, a 47% increase over 2011 first quarter revenues of $1.12 million.

15 May 2012

Conmed signs new contract with Howard County

Conmed Healthcare Management, Inc., a leading full service provider of correctional facility healthcare services to county detention centers, today announced that it has signed an agreement with Howard County, Maryland for an initial one-year term with options for nine one-year extensions, which are at the County's option effective July 1, 2012.

15 May 2012

BioAlliance Pharma commences Livatag phase III trial in hepatocellular carcinoma

BioAlliance Pharma SA, a Company dedicated to orphan oncology products and specialty products, today announces the initiation of ReLive, its phase III clinical trial with Livatag(doxorubicin Transdrug), as scheduled in the advancement calendar of the project.

15 May 2012

Cockroaches can trigger allergy and asthma attacks

In recognition of National Asthma and Allergy Awareness Month, celebrated in May, the National Pest Management Association (NPMA) is reminding people that cockroaches can trigger asthma and allergy attacks, along with other pertinent diseases.

15 May 2012

Lilly to present oncology data from more than 25 studies at ASCO annual meeting

Eli Lilly and Company will present data from more than 25 studies at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from June 1 – 5, 2012, including overall survival results from PARAMOUNT, a Phase III study of an ALIMTA (pemetrexed for injection)-based continuation maintenance regimen for the treatment of advanced nonsquamous non-small cell lung cancer.

15 May 2012

Accellent first quarter net sales increase 1.3% to $131.6 million

Accellent Inc., a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal first quarter ended March 31, 2012.

15 May 2012

Menarini, Furiex enter license agreement to commercialize Priligy

Furiex Pharmaceuticals, Inc. and Menarini Group today announced that they have entered into a license agreement by which Furiex will license to Menarini rights to commercialize Priligy in Europe, most of Asia, Africa, Latin America and the Middle East.

15 May 2012

Fibrocell submits azficel-T Phase II study protocol with FDA to treat restrictive burn scars

Fibrocell Science, Inc. announced today that is has submitted to the U.S. Food & Drug Administration (FDA) the company's Phase II clinical study protocol to evaluate the safety and efficacy of Fibrocell's lead therapy, azficel-T, in improving the range of motion, function and flexibility, in patients with existing restrictive burn scars.

15 May 2012

Electromed third quarter net revenues decrease 8.2% to $4,774,000

Electromed, Inc. today announced financial results for the three-month period ended March 31, 2012.

15 May 2012

Study identifies how skeletal muscle stem cells respond to muscle injury

A study conducted by Children's Hospital & Research Center Oakland scientists identifies how skeletal muscle stem cells respond to muscle injury and may be stimulated to improve muscle repair in Duchenne Muscular Dystrophy, a severe inherited disease of muscle that causes weakness, disability and, ultimately, heart and respiratory failure.

15 May 2012

MicroRNA-3151 a new independent prognostic marker for acute leukemia

A study has identified microRNA-3151 as a new independent prognostic marker in certain patients with acute leukemia. The study involves patients with acute myeloid leukemia and normal-looking chromosomes.

15 May 2012

As MDGs set to expire in 2015, U.N. panel to advise on approaches to development; African Progress Panel calls for 'big push' on continent

"The presidents of Indonesia and Liberia -- Susilo Bambang Yudhoyono and Ellen Johnson Sirleaf -- and the prime minister of the United Kingdom, David Cameron, are to co-chair a U.N. panel to advise on approaches to development after the Millennium Development Goals (MDGs) expire in 2015," SciDev.Net reports.

14 May 2012

Acupuncture may improve dyspnea in COPD patients

According to a small clinical trial reported by investigators from Japan, acupuncture appears to be associated with improvement of dyspnea (labored breathing) on exertion, in patients with chronic obstructive pulmonary disease (COPD), according to a study published Online First by Archives of Internal Medicine, a JAMA Network publication.

14 May 2012